In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis

von Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques
Veröffentlicht 2007

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

von Converse, Paul J., Almeida, Deepak V., Nuermberger, Eric L., Grosset, Jacques H.
Veröffentlicht 2011

Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

von Converse, Paul J, Nuermberger, Eric L, Almeida, Deepak V, Grosset, Jacques H
Veröffentlicht 2011

Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?

von Rosenthal, Ian M., Zhang, Ming, Almeida, Deepak, Grosset, Jacques H., Nuermberger, Eric L.
Veröffentlicht 2008

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

von Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.
Veröffentlicht in Antimicrob Agents Chemother (2019)

Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

von Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.
Veröffentlicht 2008

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

von Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques
Veröffentlicht 2009

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice

von Almeida, Deepak, Converse, Paul J., Ahmad, Zahoor, Dooley, Kelly E., Nuermberger, Eric L., Grosset, Jacques H.
Veröffentlicht 2011

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy

von Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Veröffentlicht 2013

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

von Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.
Veröffentlicht 2013

Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations

von Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Veröffentlicht in Antimicrob Agents Chemother (2015)

Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with Mycobacterium ulcerans Infection

von Zhang, Tianyu, Li, Si-Yang, Converse, Paul J., Almeida, Deepak V., Grosset, Jacques H., Nuermberger, Eric L.
Veröffentlicht 2011

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease

von Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.
Veröffentlicht 2013

Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

von Almeida, Deepak V., Converse, Paul J., Omansen, Till F., Tyagi, Sandeep, Tasneen, Rokeya, Kim, Jeongjun, Nuermberger, Eric L.
Veröffentlicht in Antimicrob Agents Chemother (2020)

Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease

von Sarfo, Fred Stephen, Converse, Paul J., Almeida, Deepak V., Zhang, Jihui, Robinson, Clive, Wansbrough-Jones, Mark, Grosset, Jacques H.
Veröffentlicht 2013

Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

von Almeida, Deepak, Ioerger, Thomas, Tyagi, Sandeep, Li, Si-Yang, Mdluli, Khisimuzi, Andries, Koen, Grosset, Jacques, Sacchettini, Jim, Nuermberger, Eric
Veröffentlicht in Antimicrob Agents Chemother (2016)

Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis

von Nuermberger, Eric, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy N., Almeida, Deepak, Peloquin, Charles A., Bishai, William R., Grosset, Jacques H.
Veröffentlicht 2006

Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis

von Xu, Jian, Tasneen, Rokeya, Peloquin, Charles A., Almeida, Deepak V., Li, Si-Yang, Barnes-Boyle, Kala, Lu, Yu, Nuermberger, Eric
Veröffentlicht in Antimicrob Agents Chemother (2017)

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

von Almeida, Deepak V., Omansen, Till F., Li, Si-Yang, Lee, Jin, Grosset, Jacques H., Converse, Paul J., Nuermberger, Eric L.
Veröffentlicht in Antimicrob Agents Chemother (2019)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice

von Almeida, Deepak V., Tyagi, Sandeep, Li, Si-Yang, Wallengren, Kristina, Pym, Alexander S., Ammerman, Nicole C., Bishai, William R., Grosset, Jacques H.
Veröffentlicht in Mycobact Dis (2014)